Annals of Internal Medicine · 1993 · 66 citations · 7 references
MedicineImmunologySurgeryTransplant ImmunologyTransplant PharmacotherapyTransplant SurgeryLiver Transplant ImmunosuppressionLiver Transplant PharmacotherapyLiver TransplantationTransplant PharmacologyTransplant RejectionAllograft Survival AssessmentImmunosuppression RegimensImmunosuppressive CompoundsImmunosuppressive ConditioningLiver Transplantation ManagementPost-transplant ImmunosuppressionRecipient Graft SurvivalSelection Of Comparison Groups
The effects of liver transplantation and the obligate use of cyclosporine on the subsequent clinical course of nine patients with sarcoidosis were examined. Two comparison groups, each consisting of 18 patients without sarcoidosis, were also studied. The liver allograft recipients received either cyclosporine or FK 506 as their primary immunosuppressive agent. Patient and graft survival were assessed for all three groups. In patients with sarcoidosis before transplantation, evidence for continued disease activity after transplantation was also assessed. Patient and allograft survival were excellent. No clinical evidence of continued disease activity was noted. Thus, the presence of sarcoidosis is not a contraindication for liver transplantation in otherwise appropriate candidates for the procedure.
7
Cyclosporine and Chronic Sarcoidosis
Ernest L. York, Thavisakdi Kovithavongs, Paul Man et al. · CHEST Journal · 1990 · 44 citations
Uveitis, cutaneous and neurosarcoid: treatment with low-dose cyclosporine A.
Leonard Bielory, Christine Holland, Pierre Gascon et al. · PubMed · 1988 · 20 citations